Today the US Food and Drug Administration (FDA) approved secukinumab (Cosentyx) for the treatment of adults with polymyalgia rheumatica (PMR) who have had an inadequate response to corticosteroids or who cannot tolerate corticosteroid taper. This is the first anti-IL-17 biologic approved for
Dr. Cush reviews best reasons to go to ACR annually, but also the best way to learn ACR26 content this year.
Obesity, in particular in psoriatic arthritis (PsA) was widely covered at #ACR26. This is from the recognition of the size of the problem.
Today the ACR began with the Great Debate, an intriguing set of Plenary presentations, a never-ending poster hall and a plethora of stimulation oral presentation sessions. Here are a few of my favorites from today:
Pain, fatigue and poor sleep are common concerns for people living with RA. In women approaching or experiencing menopause, joint and muscle pain, mood changes and sleep difficulties are recognised menopause-associated symptoms. A study from Mayo Clinic at this year’s ACR Convergence examines
